Research programme: interferon-alpha biosynthesis stimulants - 3M Pharmaceuticals
Alternative Names: Interferon-alpha biosynthesis stimulants research programme - 3M PharmaceuticalsLatest Information Update: 22 Apr 2003
At a glance
- Originator 3M Pharmaceuticals
- Class
- Mechanism of Action Interferon alpha stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Viral infections
Most Recent Events
- 02 May 2001 Preclinical development for Viral infections in USA (Unknown route)